Knopp Biosciences

Knopp Biosciences was founded in 2004, with the mission to discover, develop, and deliver breakthrough medicines for urgent unmet medical needs. They are currently developing potassium channel modulators that could be used to treat neuropathic pain, epilepsy and tinnitus.

Clinical trials to be announced.